Multi-year Revenue DeclineSustained top-line contraction (2025 ~21% down vs 2024) erodes scale and limits fixed-cost absorption. Over several months this weakens competitive positioning, reduces reinvestment capacity, and makes margin recovery and product investment more difficult without structural changes.
Structural UnprofitabilityPersistent negative operating and net margins across multiple years indicate structural profitability issues. Continued losses deplete equity and restrict reinvestment, forcing reliance on external funding and increasing the risk that operations cannot sustain long-term strategic initiatives.
Rising Leverage And Shrinking EquityEquity collapsed while debt stayed near ~HK$30M, lifting debt/equity to ~4.0x. Elevated leverage materially reduces financial flexibility, raises refinancing and covenant risk, and magnifies downside from ongoing cash burn unless profitability or funding is restored.